|
BMP2K expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.121420E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.827730E-02 |
| Normal-vs-Stage2 |
6.562100E-03 |
| Normal-vs-Stage3 |
1.322810E-01 |
| Normal-vs-Stage4 |
9.422000E-01 |
| Stage1-vs-Stage2 |
3.518000E-02 |
| Stage1-vs-Stage3 |
9.478200E-01 |
| Stage1-vs-Stage4 |
3.164000E-01 |
| Stage2-vs-Stage3 |
1.086790E-01 |
| Stage2-vs-Stage4 |
4.393900E-02 |
| Stage3-vs-Stage4 |
3.249400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.197900E-03 |
| Normal-vs-AfricanAmerican |
3.084400E-02 |
| Normal-vs-Asian |
8.793000E-01 |
| Caucasian-vs-AfricanAmerican |
8.618400E-01 |
| Caucasian-vs-Asian |
4.948000E-01 |
| AfricanAmerican-vs-Asian |
5.203800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.841800E-03 |
| Normal-vs-Female |
9.788900E-04 |
| Male-vs-Female |
6.327900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.081700E-02 |
| Normal-vs-Extreme_Weight |
2.347200E-01 |
| Normal-vs-Obese |
8.122900E-03 |
| Normal-vs-Extreme_Obese |
2.577600E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.992790E-01 |
| Normal_Weight-vs-Obese |
9.461800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.547600E-01 |
| Extreme_Weight-vs-Obese |
5.844400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.967200E-01 |
| Obese-vs-Extreme_Obese |
7.826200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.335960E-01 |
| Normal-vs-Age(41-60Yrs) |
2.299400E-03 |
| Normal-vs-Age(61-80Yrs) |
1.610180E-02 |
| Normal-vs-Age(81-100Yrs) |
1.262800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.988600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.596000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.362400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.639000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.719400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.068400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.414000E-02 |
| Normal-VS-Type2 PRCC |
2.737700E-03 |
| Normal-VS-KIRP CIMP |
1.877590E-01 |
| Normal-VS-Unclassified PRCC |
9.566600E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.840100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.453200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.490280E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.266200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.791000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.605200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.299180E-01 |
| Normal-vs-N1 |
7.466400E-02 |
| Normal-vs-N2 |
3.713000E-01 |
| N0-vs-N1 |
4.070600E-01 |
| N0-vs-N2 |
3.035000E-01 |
| N1-vs-N2 |
2.326800E-01 |
|
|
